...
机译:组合型辅助治疗治疗Ⅱ期IIIC子宫内膜和非内辅内膜子宫内膜癌的存活结果
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Orlando Hlth UF Hlth Canc Ctr Dept Radiat Oncol Orlando FL USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Gynecol Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Gynecol Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Gynecol Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
机译:组合型辅助治疗治疗Ⅱ期IIIC子宫内膜和非内辅内膜子宫内膜癌的存活结果
机译:早期子宫非内甲状腺体癌患者的妇女生存结果与辅助化疗和阴道近距离放射治疗
机译:早期高级别子宫内膜癌患者子宫内膜样和非子宫内膜样肿瘤的可比结果
机译:None
机译:阶段T4B头部和颈部癌症生存结果比较基于治疗方式:手术是可行的治疗选项吗?
机译:淋巴结比率对IIIC期子宫内膜样子宫内膜癌生存的影响:土耳其妇科肿瘤小组研究
机译:组合型辅助治疗治疗Ⅱ期IIIC子宫内膜和非内辅内膜子宫内膜癌的存活结果